We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
-8.77%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$6.11B
AUM Growth
+$521M
Cap. Flow
+$1.01B
Cap. Flow %
16.59%
Top 10 Hldgs %
33.99%
Holding
4,384
New
1,099
Increased
1,206
Reduced
959
Closed
1,079

Sector Composition

Rank Sector Weight
1 Healthcare 4.24%
2 Consumer Discretionary 3.15%
3 Financials 3.03%
4 Technology 2.74%
5 Industrials 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHE
3101
Alterity Therapeutics
ATHE
$80M
$28K ﹤0.01%
513
-1,940
-79% -$123K
GIGM icon
3102
GigaMedia
GIGM
$15.7M
$28K ﹤0.01%
+11,274
New +$35.2K
QMCO icon
3103
Quantum Corp
QMCO
$419M
$28K ﹤0.01%
252
+88
+54% +$16.3K
NETI
3104
DELISTED
Eneti Inc.
NETI
$28K ﹤0.01%
171
-780
-82% -$146K
APEN
3105
DELISTED
Apollo Endosurgery, Inc.
APEN
$28K ﹤0.01%
1,931
+311
+19% +$5.92K
CRMD icon
3106
CorMedix
CRMD
$591M
$27K ﹤0.01%
+2,721
New +$42K
PDEX icon
3107
Pro-Dex
PDEX
$187M
$27K ﹤0.01%
+10,924
New +$25.8K
C.WS.A
3108
DELISTED
Citigroup Inc
C.WS.A
$27K ﹤0.01%
57,648
+347
+0.6% +$228
CPXX
3109
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$27K ﹤0.01%
16,297
-21,747
-57% -$48.3K
CTCM
3110
DELISTED
CTC MEDIA INC COM STK
CTCM
$27K ﹤0.01%
15,147
-62,352
-80% -$115K
BIOL
3111
DELISTED
Biolase, Inc.
BIOL
$26K ﹤0.01%
+2
New +$37.2K
ATRS
3112
DELISTED
Antares Pharma, Inc.
ATRS
$26K ﹤0.01%
15,216
-2,096
-12% -$4.11K
GV
3113
DELISTED
Goldfield Corporation
GV
$26K ﹤0.01%
+15,487
New +$25.6K
DZSI
3114
DELISTED
DZS Inc. Common Stock
DZSI
$26K ﹤0.01%
3,773
-9,931
-72% -$88.1K
NES
3115
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$26K ﹤0.01%
+19,225
New +$52.9K
DOM
3116
DELISTED
DOMINION RES BLACK WARRIOR TR
DOM
$26K ﹤0.01%
+17,978
New +$38.9K
RCPI
3117
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$26K ﹤0.01%
31,116
-43,097
-58% -$48K
KIQ
3118
DELISTED
Kelso Technologies Inc.
KIQ
$26K ﹤0.01%
+16,248
New +$35.5K
WRES
3119
DELISTED
WARREN RESOURCES INC
WRES
$26K ﹤0.01%
53,561
+39,881
+292% +$18.3K
AMD icon
3120
CALL
Advanced Micro Devices
AMD
$776B
$25K ﹤0.01%
14,600
-7,800
-35% -$14.7K
AMD icon
3121
Advanced Micro Devices
AMD
$776B
$25K ﹤0.01%
14,470
-152,203
-91% -$286K
SLNO
3122
DELISTED
Soleno Therapeutics
SLNO
$25K ﹤0.01%
159
-26
-14% -$4.71K
VXRT
3123
DELISTED
Vaxart
VXRT
$25K ﹤0.01%
1,130
-750
-40% -$18.2K
AXAS
3124
DELISTED
Abraxas Petroleum Corp
AXAS
$25K ﹤0.01%
967
+425
+78% +$15.8K
GLBR
3125
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$25K ﹤0.01%
2,903
-16,108
-85% -$167K

Similar funds

Virtu KCG Holdings's Q3 2015 Portfolio in Review

As of Q3 2015, Virtu KCG Holdings held 4,384 positions worth $6.11B, up 9.3% from $5.59B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Virtu KCG Holdings deployed $1.01B of net new capital in Q3 2015, opening 1,099 new positions and adding to 1,206 existing holdings. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 91,696 shares worth $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 4.2% of assets, up from 3.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $63.1M trimmed.

  • Virtu KCG Holdings's largest Q3 2015 buy was iShares 3-7 Year Treasury Bond ETF: 91,696 shares worth $11.4M.
  • Virtu KCG Holdings added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2015, an estimated $45M increase.
  • Virtu KCG Holdings's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $63.1M.
  • Virtu KCG Holdings fully exited Vanguard Total Bond Market in Q3 2015, selling an estimated $14.9M.
  • Virtu KCG Holdings's ten largest holdings make up 34% of its $6.11B portfolio in Q3 2015.
  • Virtu KCG Holdings opened 1,099 new positions and closed 1,079 in Q3 2015.
  • Virtu KCG Holdings's portfolio value rose 9.3% quarter-over-quarter to $6.11B.

Based on Virtu KCG Holdings's 13F filing for Q3 2015, filed 13 Nov 2015.